CN104749371A - An enzyme-linked immunosorbent assay kit for human nephroblastoma-overexpressed gene encoded protein - Google Patents

An enzyme-linked immunosorbent assay kit for human nephroblastoma-overexpressed gene encoded protein Download PDF

Info

Publication number
CN104749371A
CN104749371A CN201310736748.3A CN201310736748A CN104749371A CN 104749371 A CN104749371 A CN 104749371A CN 201310736748 A CN201310736748 A CN 201310736748A CN 104749371 A CN104749371 A CN 104749371A
Authority
CN
China
Prior art keywords
nov protein
nov
protein
antibody
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310736748.3A
Other languages
Chinese (zh)
Other versions
CN104749371B (en
Inventor
谢良志
张�杰
王加兰
张娜娜
朱萍霞
何群香
赵静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENZHOU CELL ENGINEERING Co Ltd
Original Assignee
SHENZHOU CELL ENGINEERING Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENZHOU CELL ENGINEERING Co Ltd filed Critical SHENZHOU CELL ENGINEERING Co Ltd
Priority to CN201310736748.3A priority Critical patent/CN104749371B/en
Publication of CN104749371A publication Critical patent/CN104749371A/en
Application granted granted Critical
Publication of CN104749371B publication Critical patent/CN104749371B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541Double or second antibody, i.e. precipitating antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a double-antibody sandwich ELISA kit for human nephroblastoma-overexpressed gene encoded protein (NOV protein) and a preparing method thereof. The kit comprises an ELISA plate precoated with an NOV protein monoclonal antibody, an enzyme-labeled NOV protein rabbit polyclonal antibody, a washing liquid, a diluting liquid, a coloring liquid, a terminating liquid and a protein standard substance. The kit has characteristics of high sensitivity, high specificity, capability of being quantitative, accurate, simple and easy to use, good reproducibility, and the like, can rapidly detect a large number of samples simultaneously, can be used for qualitative and quantitative detection of the NOV protein in base and clinical research, and has a wide application prospect.

Description

People's nephroblastoma overepressed gene encoding proteins enzyme linked immunological kit
Technical field
The one that the present invention relates in technical field of immunoassay detects the double-antibody sandwich elisa kit of people's nephroblastoma overepressed gene encoding proteins (nov protein).
Background technology
People's nephroblastoma overepressed gene encoding proteins (Nephroblastoma-overexpressed geneprotein homolog, NOV), i.e. nov protein, also referred to as CCN3 albumen (CCN family member3) or insulin-like growth factor bindin 9 (Insulin-like growth factor-binding protein9, IGFBP9).Nov protein belongs to CCN family, and this family is made up of the secreting glycoprotein that one group of structure is similar, and family member known at present comprises CCN1 to CCN6 totally six kinds of albumen.CCN family protein cell propagation, break up and stick and vascularization, tumour occur and progression in all there is vital role.
NOV has multiple different physiological action, such as there is research display NOV to have to promote human nerve stem carefully to roar propagation and promote the effect of its Differentiating Into Neurons, delay the renal tubule transdifferentiation process caused by TGF-β 1 and play an important role in the generation of gestational diabetes mellitus.In addition, nov protein also can be used as the early diagnosis marker of pregnant pre-eclampsia.Meanwhile, existing many result of study display NOV are the marks of a novel tumour: NOV content is that positivity is relevant to melanomatous malignant degree; Overexpression nov protein can promote growth, the migration and invasion of esophageal cancer cell; The positive expression rate of NOV in cervical cancer tissues is apparently higher than the positive expression rate in normal cervical tissues, and the tumor size of the expression of NOV and cervical carcinoma and lymphatic metastasis etc. have significant correlation, illustrate that the expression of NOV is with the generation of cervical carcinoma with develop relevant, is considered to can be used as the diagnosis of cervical carcinoma and the molecular marker of clinical monitoring; NOV judges malignancy to have researcher to think, i.e. cell adhesion and the mark of invading profit.
NOV is as important biomarker, it detects research to tumour genesis mechanism, the tracking of development, Index for diagnosis and clinical treatment is quickly and accurately very crucial, thus need to set up a kind of easy, effective, can be used for all kinds of common sample as serum, blood plasma carry out the technical method that high flux detects fast.Compared with other technology, solid-phase enzyme-linked immune method because highly sensitive, specificity good, testing cost is low, simple to operate, be applicable to during analysis that the advantage such as pattern detection in enormous quantities is widely used in various important biomolecule mark detects.Current domestic conventional nov protein enzyme linked immunological kit mainly relies on import, expensive, the arrival cycle is long, and the domestic nov protein clinical diagnosis product still do not ratified through national Bureau of Drugs Supervision, therefore need exploitation associated antibodies and kit badly, support every fundamental research of domestic nov protein, break the corner on the market of imported product, and providing critical material for developing clinical in vitro diagnosis in vitro reagent further, expedite product is developed, and fills the domestic gaps.
Summary of the invention
The object of this invention is to provide that a kind of detection sensitivity is high, accuracy be strong, the double-antibody sandwich elisa kit of people's nephroblastoma overepressed gene encoding proteins (nov protein) of low cost.
Detection kit provided by the present invention comprises specific nov protein coated antibody, and the nov protein of enzyme labeling detects the standard items of antibody and nov protein.
Wherein said nov protein coated antibody is mouse monoclonal antibody, and its light chain and heavy chain amino acid sequence are respectively SEQ ID NO:1 and SEQ ID NO:2, and it is rabbit polyclonal antibody that described enzyme mark detects antibody, and described nov protein standard items are restructuring nov protein.
Described monoclonal antibody adopts restructuring nov protein immune animal, utilizes hybridoma technology to prepare.Described polyclonal antibody adopts restructuring nov protein immune animal, is prepared by Protein A purification and antigen affinity purification technology.Enzyme labelled antibody conventionally utilizes horseradish peroxidase (Horseradishperoxidase, HRP) labelled antibody to obtain.
Technical scheme of the present invention is preferred high sensitivity, the monoclonal antibody of high specific and polyclonal antibody carry out combinations of pairs, monoclonal antibody is adsorbed on solid phase carrier as coated antibody, coated antibody specificly can catch nov protein in sample and nov protein standard items, after adding enzyme mark detection antibody, form coated antibody, antigen, detection antibody complex, stop after corresponding substrate colour developing, read sample light absorption value, compare the content that can draw nov protein with typical curve.
The present invention adopts the nov protein level in the legal or quantitative detection sample of double antibodies sandwich, the method of inspection is convenient and easy, detection sensitivity and accuracy is high, high specificity, simultaneously can detect sample in enormous quantities fast, bag quilt and the detection antibody of kit chief component are independent research, therefore cost is low, reliability strong, plays a significant role in the relevant rudimentary and clinical research of nov protein.
Accompanying drawing explanation
The examination criteria curve map of Fig. 1 .NOV enzyme linked immunological kit
Embodiment
Below in conjunction with specific embodiment, the present invention will be further described and explanation.
The component preparation of embodiment 1 enzyme-linked immunologic detecting kit
1, the preparation of restructuring nov protein standard items
Standard items in described kit are restructuring nov protein, from Sino Biological Inc. (article No. is: 10264-H08B), this albumen utilizes insect cell to express in vitro, then the high purity N OV albumen of purifying acquisition, have biologically active, concrete activity and purity data can see the explanation of Yi Qiao Divine Land company's site for this product.
2, the preparation of nov protein mouse monoclonal antibody
1) animal immune
Select Balb/c mouse as immune animal, with above-mentioned restructuring nov protein for immunogene carries out immunity, immunizing dose is the nov protein of every mouse immune 50 μ g at every turn.During first immunisation, the complete Freund's adjuvant of immunogene and equivalent is made emulsifying agent, subcutaneous abdomen multi-point injection, interval gets same dose immunogene after 2 ~ 3 weeks and equivalent incomplete Freund's adjuvant makes emulsifying agent, booster immunization twice, indirect elisa method is used to measure serum titer after three immunity, serum titer reaches after 1: 16000, and once, after 4 days, extracting spleen cell carries out Fusion of Cells to the mouse peritoneal booster immunization that selection is tired the highest.
2) Fusion of Cells and cloning
Get mouse spleen, the rear single splenocyte suspension of centrifugal acquisition is filtered in grinding, after cell count, ratio in 5: 1 or 10: 1 mixes with the SP2/0 murine myeloma cell being in exponential phase, adopts polyglycol (PEG) method to carry out Fusion of Cells, bed board, by the effect of Selective agar medium, myeloma cell and splenocyte etc. do not merge or the cell of fusion not yet in effect cannot grow, and the hybridoma of effective integration will grow, breed in culture hole, and secretory antibody.After changing liquid three times, within 9-12 days, cells and supernatant is got after merging, using nov protein of recombinating as envelope antigen, indirect elisa method is utilized to measure supernatant, screen positive hole, and by limiting dilution assay, colonized culture is carried out to positive cell, until obtain the monoclonal hybridoma strain of the anti-nov protein specific antibody of stably excreting.Above Fusion of Cells and cloning method are the conventional classical way in immunology monoclonal antibody technique.
3) production of monoclonal antibody and purifying
Choose hybridoma cell strain, culture flask or bio-reactor is utilized to carry out cell chulture, collecting cell culture supernatant, routine protein A affinity column is utilized to carry out purifying, the antibody obtained is by packing after SDS-PAGE electrophoresis and indirect elisa method qualification antibody purity and specificity, for subsequent use in-20 DEG C of Cord blood.
4) sequencing of monoclonal antibody
Hybridoma is preserved for a long time and positive colony may be caused to lose due to unstable after repeatedly going down to posterity and pollution problem, for solving the problem, in process of the present invention, Protocols in Molecular Biology is utilized to be extracted light chain of antibody and the heavy chain gene of positive colony respectively, carry out sequencing, the plasmid including antibody gene can steady in a long-termly under-20 DEG C of conditions be preserved, simultaneously, according to antibody gene sequences, the technician in this professional domain conveniently can obtain identical monoclonal antibody by molecular biology method clonal expression.
It is as follows that antibody gene extracts amplification concrete grammar: collect the hybridoma that growth conditions is good, hybridoma total serum IgE is extracted by the operation scheme of the classical total RNA isolation kit instructions of BBI company, by electrophoresis detection quality, UV measures concentration.Be cDNA by the operation scheme of the MMLV first strand cDNAsynthesis kit instructions of BBI company by mRNA reverse transcription ,-20 DEG C frozen for subsequent use.Reverse transcription reaction system is: 11 μ l RNA (2.7 μ g), 5 × reaction buffer4 μ l, RNase inhibitor (20U/ μ l) 1 μ l, dNTP mix (10mmol/L) 2 μ l, M-MuLV reverse transcriptase1 μ l, total reaction volume is 20 μ l.According to list of references design primer, take cDNA as light chain and the heavy chain fragment that template difference PCR obtains antibody.PCR reaction system is: 2.0 μ l10 × Pyrobest buffer, 1.6 μ l2.5mM dNTP, 1.4 μ l10 μM primer pairs, 0.4 μ l hybridoma cDNA, and 0.2 μ l5U/ μ l Pyrobest DNAPolymerase, reaction system is 20 μ l.Amplification condition: sex change 94 DEG C of 4min; Sex change 94 DEG C of 1min, anneal 58 DEG C of 1min, extends 72 DEG C of 1min, 30 circulations; Extend 72 DEG C of 5min.Light chain and heavy chain fragment are inserted on pcDNA3T carrier, build pcDNA3-anti-NOV-L and pcDNA3-anti-NOV-H carrier.By vector Escherichia coli, picking positive colony, carries out order-checking qualification, analyzes sequencing result, obtain correct light chain and heavy chain amino acid sequence.The light-chain amino acid sequence that measurement result and sequential analysis show this antibody is SEQ ID NO:1; Heavy chain amino acid sequence is SEQ ID NO:2, refers to sequence table.Specific experiment operation is with reference to [Sa curtain Brooker J etc., " molecular cloning texts guide ", Beijing Science Press] well known to those skilled in the art.
3, the preparation of nov protein rabbit polyclonal antibody
Choose new zealand rabbit as immune animal, carry out immunity with nov protein of recombinating for immunogene, immunizing dose is the nov protein of every rabbit immune 500 μ g at every turn.The complete Freund's adjuvant of immunogene and equivalent is made emulsifying agent by first immunisation, neck dorsal sc multi-point injection, interval gets same dose immunogene in 2 ~ 3 weeks and equivalent incomplete Freund's adjuvant makes emulsifying agent, booster immunization, immune 4-5 time altogether, indirect elisa method measures serum titer and reaches after 1: 25000, heart extracting blood, by obtaining the polyclonal antibody of purifying after routine protein A affinity column and nov protein antigen affinity column two-step purifying, packing, is used for the preparation of enzyme labelled antibody in-20 DEG C of Cord blood.Wherein nov protein antigen affinity purification concrete steps are as follows:
A) Ago-Gel (GE company) of 0.7g cyanogen bromide-activated is claimed, swelling with 1mM HCl, then wash three times with 1mM HCl, for subsequent use;
B) nov protein getting 2mg utilizes hyperfiltration process albumen buffer exchange to be become 0.1M NaHCO3, pH8.3, and to control volume be 1 ~ 2ml;
C) joined by protein solution in the activated sepharose that step a) washed, room temperature shakes 4h;
D) with the Tris buffer blind unreacted group of pH8.0,0.1M;
E) fill gravity post, bed volume is about 2ml, rinses, and balance with PBS;
F) get Protein A purification how anti-cross post, rinse non-binding antibody with PBS, with the antibody of pH3.0 citrate buffer solution wash-out specific bond, with in Tris damping fluid and eluent to pH7.0-7.5.
4, the preparation of enzyme labelled antibody
A) HRP taking 5mg is dissolved in 0.5mL distilled water;
B) NaIO of the 0.1M that 0.5mL newly joins is added 4solution, under room temperature, lucifuge stirs 20 minutes;
C) loaded in bag filter by above-mentioned solution, the sodium-acetate buffer (pH4.4) of 1mM is dialysed 4 DEG C and is spent the night;
D) get the polyclonal antibody of 5mg affinity purification, join in 1mL0.01M carbonate buffer solution, for subsequent use;
E) in c) liquid, add 0.2M carbonate buffer solution (pH9.5), make pH be elevated to 9.0 ~ 9.5, then add immediately d) in liquid, room temperature lucifuge stirs 2 hours gently;
F) 4mg/mLNaBH that 0.2mL now joins is added 4liquid, mixing, places 2 hours in 4 DEG C;
G) loaded in bag filter by above-mentioned liquid, dialyse in the PBS of pH7.4,0.15M, 4 DEG C are spent the night.
Embodiment 2 detects the establishment of the enzyme linked immunological kit of nov protein
Set up the enzyme linked immunological kit detecting nov protein, comprise following reagent:
A) anti-nov protein mouse monoclonal antibody;
B) the anti-nov protein rabbit polyclonal antibody of HRP mark;
C) restructuring nov protein standard items;
D) bag is buffered liquid: the carbonate buffer solution of pH9.6,0.05mol/L;
E) confining liquid: the Tris damping fluid containing 2% bovine serum albumin(BSA);
F) sample diluting liquid: the phosphate buffer containing 0.1% bovine serum albumin(BSA);
G) cleansing solution: the phosphate buffer containing 0.1% tween;
H) substrate nitrite ion: be made up of nitrite ion A and nitrite ion B, nitrite ion A is hydrogen peroxide or urea peroxide, and nitrite ion B is tetramethyl biphenyl;
The sulfuric acid of i) stop buffer: 2mol/L.
The preparation of embodiment 3NOV enzyme linked immunological kit
1. utilize orthogonal test to grope optimum antibody combination and the working concentration of enzyme linked immunological kit
Ultraviolet spectrophotometer method is used to measure the concentration of antibody and antigen.Orthogonal test method is adopted to grope optimum antibody combination and optimum antibody working concentration, being diluted by anti-for difference nov protein mouse monoclonal antibody is 4 μ g/mL, 2 μ g/mL, 1 μ g/mL and 0.5 μ g/mL, the anti-nov protein rabbit polyclonal antibody dilution of HRP mark is 2 μ g/mL, 1 μ g/mL, 0.5 μ g/mL and 0.25 μ g/mL, and standard concentration is 1000pg/mL, 100pg/mL and 0pg/mL.Consider the absorbance value in blank well background and positive test hole, optimize a strain mouse monoclonal antibody as coated antibody, and confirm that its best effort concentration is that to mark the best effort concentration of polyclonal antibody be 0.5 μ g/mL for 2 μ g/mL, HRP.
2. the batch preparation of kit
1) a large amount of preparations of ELISA Plate:
Anti-nov protein antibody dilution to concentration is 2 μ g/mL by coated elisa plate: be buffered liquid with carbonate bag, and 100 μ L/ holes, wrap by 96 hole ELISA Plate, 4 DEG C of overnight incubation; Plate is washed 1 time, 200 μ L/ holes with cleansing solution; Close: every hole adds 300 μ L confining liquids and closes nonspecific binding site, incubated at room 1 hour; Then plate is washed 2 times with cleansing solution, 200 μ L/ holes; Pat dry rear vacuum packing machine packaging, 4 DEG C save backup.
2) a large amount of preparations of protein standard substance: dilute nov protein with sample diluting liquid, freeze-drying after packing, 4 DEG C save backup.
3) a large amount of preparations of enzyme labelled antibody: by how anti-for the anti-nov protein after affinity purification with HRP mark, add 50% glycerine, after packing ,-20 DEG C save backup.
The mensuration of embodiment 4NOV enzyme linked immunological kit major parameter
The major parameter of kit is measured, comprises the specificity of kit, accuracy and precision, concrete grammar and result as follows:
1. the specific detection of kit
Recombinant human protein EGF, TNFa, IL33, AFP, TIMP1, BAFF, HGF, TGF-β 1, γ-IFN and IGF1 are diluted to 100ng/mL, detect with nov protein enzyme-linked immunologic detecting kit, experiment results proved, people EGF, TNFa, IL33, AFP, TIMP1, BAFF, HGF, TGF-β 1 of this kit and 100ng/mL, the equal no cross reaction of γ-IFN and IGF1, show this kit specificity better.
2, the accuracy determination of kit
Carry out the accuracy of detection kit by adding recovery experiment, in human serum sample, add restructuring nov protein, the nov protein concentration of adding is 1.6ng/mL, 0.4ng/mL, 0.05ng/mL and 0ng/mL.Then with prepared kit, sample after interpolation is detected.Calculate the nov protein content in each sample according to typical curve, namely the nov protein content deducted in blank serum obtain measured nov protein content, and the protein content added divided by theory is TIANZHU XINGNAO Capsul.The results are shown in Table 1, result display TIANZHU XINGNAO Capsul is 95%-104%, and the prepared good accuracy of kit is described, serotonin is verified and detected without obviously interference.
Table 1NOV protein reagent box accuracy determination
The restructuring nov protein concentration (ng/mL) of adding Measured value The recovery
1.6 1.664 104%
0.4 0.415 104%
0.05 0.048 95%
0 0.108 -
3, the precision of kit measures
1) replica test
Select 5 parts of blood serum samples containing different N OV protein concentration, parallel 3 pieces of ELISA Plate detections, 5, each sample repetition on every block plate, each plate arranges standard control curve respectively, calculate the coefficient of variation (C.V) of each testing result respectively, in table 2, average coefficient of variation is 6.6%, illustrates that prepared kit has good repeatability.
Batch interior replica test of table 2NOV protein reagent box
2) differences between batches detect
Select 5 parts of blood serum samples containing different N OV protein concentration, duplicate detection 7 times in batches, 3 repetitions established by each each sample, arrange standard control curve in each plate.Calculate the coefficient of variation (C.V) between same increment product 7 testing results, in table 3, the coefficient of variation average out to 13.0% of 5 increment product, 7 testing results, meets in field and generally acknowledges differences between batches standard.
Table 3NOV protein reagent box differences between batches detect
The detecting step of embodiment 5NOV enzyme linked immunological kit
1. the collection of sample, process and preservation
1) cell culture supernatant: 1000 × g removes particle and polymkeric substance in centrifugal 10 minutes, and collect supernatant ,-20 DEG C save backup.
2) serum: venous blood collection, use after not collecting blood containing thermal source and endotoxic test tube, at 4 DEG C, centrifugal 15 minutes of 1000 × g, avoids haemolysis, and collect serum ,-20 DEG C save backup.
3) blood plasma: venous blood collection, use EDTA test tube to collect blood, centrifugal 15 minutes of 1000 × g at 4 DEG C, remove cell and particle ,-20 DEG C save backup.
2. application of sample
1) standard items wrapped by good ELISA Plate and freeze-drying are taken out, add 1mL sample diluting liquid standard items are dissolved, ambient temperatare puts 20 minutes, by standard items from 2000pg/mL, do the doubling dilution of 2 times, dilute 7 points, dilution is respectively got 100 μ L and add in 96 hole ELISA Plate according to the position of following table;
2) get test serum or plasma sample, add in reacting hole, 100 μ L/ holes, incubated at room temperature 2 hours;
3) cleansing solution washes plate 3 times, and 200 μ L/ holes, pat dry ELISA Plate.
3. add detection antibody
1) HRP labelled antibody sample diluting liquid is diluted to 0.5 μ g/mL, adds in reacting hole, 100 μ L/ holes, incubated at room temperature 1 hour;
2) cleansing solution washes plate 3 times, and 200 μ L/ holes, pat dry ELISA Plate.
4. develop the color
1) add the freshly prepared substrate nitrite ion of 200 μ L, room temperature reaction 20 minutes, then add 50 μ L stop buffer cessation reactions;
2) light absorption value is read under microplate reader 450nm wavelength.
5. the foundation of typical curve
With the concentration of nov protein standard items for horizontal ordinate, light absorption value is ordinate Criterion curve (Fig. 1), can calculate the nov protein content obtained in sample according to the sample light absorption value recorded.
Embodiment 6 kit detects the application of nov protein content in human serum
Nov protein enzyme-linked immunologic detecting kit prepared by utilization measures human serum nov protein content, detects the blood serum sample of 13 Healthy Peoples altogether, the results are shown in Table 4, and in the healthy population detected, the nov protein content range of serum is 5.5 ~ 42.4ng/mL.Above result shows, utilize kit of the present invention quantitatively can detect the content of nov protein in Healthy Human Serum sample, according to existing bibliographical information, the nov protein level of tumor patient is higher than normal population, therefore, the ELISA kit sensitivity that the present invention relates to can meet research needs completely, carries out accurate quantitative analysis mensuration to the nov protein content of normal population and tumor patient.
Table 4 Healthy Human Serum nov protein assay
Healthy Human Serum Nov protein content (ng/mL)
Serum 1 17.7
Serum 2 11.9
Serum 3 11.1
Serum 4 13.2
Serum 5 5.9
Serum 6 42.4
Serum 7 14.7
Serum 8 14
Serum 9 9.4
Serum 10 10.6
Serum 11 11.4
Serum 12 5.5
Serum 13 10.5

Claims (3)

1. people's nephroblastoma overepressed gene encoding proteins (nov protein) double-antibody sandwich elisa kit, it comprises:
(1) bag is by the ELISA Plate of nov protein monoclonal antibody;
(2) the nov protein polyclonal antibody of enzyme labeling;
Wherein, the light chain of the described nov protein monoclonal antibody for coated elisa plate and heavy chain amino acid sequence are respectively SEQ ID NO:1 and SEQ ID NO:2; The NOV polyclonal antibody of described enzyme labeling is the rabbit polyclonal antibody of horseradish peroxidase-labeled.
2. nov protein double-antibody sandwich elisa kit as claimed in claim 1, is characterized in that, also comprise following reagent:
(1) nov protein standard items: recombinant expressed nov protein;
(2) cleansing solution: the phosphate buffer containing 0.1% tween;
(3) sample diluting liquid: the phosphate buffer containing 0.1% bovine serum albumin(BSA);
(4) substrate nitrite ion: be made up of A liquid and B liquid, wherein substrate nitrite ion A is hydrogen peroxide or urea peroxide; Substrate nitrite ion B is tetramethyl benzidine;
(5) sulfuric acid of stop buffer: 2mol/L.
3. the double-antibody sandwich elisa kit of nov protein as claimed in claim 1 detects the application in the reagent of people's nov protein content in preparation.
CN201310736748.3A 2013-12-30 2013-12-30 People's nephroblastoma overepressed gene encoding proteins enzyme linked immunological kit Active CN104749371B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310736748.3A CN104749371B (en) 2013-12-30 2013-12-30 People's nephroblastoma overepressed gene encoding proteins enzyme linked immunological kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310736748.3A CN104749371B (en) 2013-12-30 2013-12-30 People's nephroblastoma overepressed gene encoding proteins enzyme linked immunological kit

Publications (2)

Publication Number Publication Date
CN104749371A true CN104749371A (en) 2015-07-01
CN104749371B CN104749371B (en) 2016-09-28

Family

ID=53589362

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310736748.3A Active CN104749371B (en) 2013-12-30 2013-12-30 People's nephroblastoma overepressed gene encoding proteins enzyme linked immunological kit

Country Status (1)

Country Link
CN (1) CN104749371B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110286234A (en) * 2019-07-02 2019-09-27 安肽和(杭州)医疗科技有限公司 The protein markers of gestational diabetes mellitus and its purposes in early diagnosis in urine
CN111273029A (en) * 2020-02-25 2020-06-12 芜湖天明生物技术有限公司 rhTSG-6 double-antibody sandwich ELISA quantitative detection kit and use method and application thereof
CN113533744A (en) * 2021-07-20 2021-10-22 郑州大学 ELISA kit for detecting human sorted tubulin 17 and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004006830A2 (en) * 2002-07-17 2004-01-22 Universite Paris 7 - Denis Diderot Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux
KR20050009392A (en) * 2003-07-16 2005-01-25 주식회사 하림 A kit for diagnosing liver fibrosis through identifying an upregulated gene expression of NOV
CN1835763A (en) * 2003-06-20 2006-09-20 妙甯公司 CCN1 compositions and methods
CN102947326A (en) * 2010-04-02 2013-02-27 罗莎琳德富兰克林大学医学与科学院 Ccn3 peptides and analogs thereof for therapeutic use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004006830A2 (en) * 2002-07-17 2004-01-22 Universite Paris 7 - Denis Diderot Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux
CN1835763A (en) * 2003-06-20 2006-09-20 妙甯公司 CCN1 compositions and methods
KR20050009392A (en) * 2003-07-16 2005-01-25 주식회사 하림 A kit for diagnosing liver fibrosis through identifying an upregulated gene expression of NOV
CN102947326A (en) * 2010-04-02 2013-02-27 罗莎琳德富兰克林大学医学与科学院 Ccn3 peptides and analogs thereof for therapeutic use

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CLAUDIA R.C. VAN ROEYEN ET AL.: "A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects", 《THE AMERICAN JOURNAL OF PATHOLOGY》 *
李成仁 等: "NOV基因修饰神经干细胞移植对损伤大鼠脊髓功能恢复的影响", 《第三军医大学学报》 *
苏炳银 等: "肾母细胞瘤过度表达基因mRNA在大鼠中枢神经系统的原位杂交定位", 《解剖学报》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110286234A (en) * 2019-07-02 2019-09-27 安肽和(杭州)医疗科技有限公司 The protein markers of gestational diabetes mellitus and its purposes in early diagnosis in urine
CN110286234B (en) * 2019-07-02 2023-03-24 安肽和(杭州)医疗科技有限公司 Protein marker of gestational diabetes in urine and application thereof in early diagnosis
CN111273029A (en) * 2020-02-25 2020-06-12 芜湖天明生物技术有限公司 rhTSG-6 double-antibody sandwich ELISA quantitative detection kit and use method and application thereof
CN113533744A (en) * 2021-07-20 2021-10-22 郑州大学 ELISA kit for detecting human sorted tubulin 17 and preparation method thereof

Also Published As

Publication number Publication date
CN104749371B (en) 2016-09-28

Similar Documents

Publication Publication Date Title
EP2458378B1 (en) Insulin measurement method
CN109580959B (en) ELISA kit for detecting heparin-binding epidermal growth factor
CN101088010B (en) Reagent for assaying antigen and method of assaying antigen
CN104792997A (en) Human procalcitonin immunodetection kit, and preparation method and application thereof
WO2016011852A1 (en) Bladder tumor-associated antigen detection kit
EP2006685A1 (en) Immune agglutination reaction reagent kit and method of assaying antigen
CN104099300A (en) Hybridoma cell line able to secrete anti-bovine immunoglobulin IgG monoclonal antibody and application thereof
CN103487586A (en) Testing device for quantitatively detecting soluble growth stimulation expression protein 2
CN108700576A (en) The system for preparing the application of the method, kit and kit of antibody pair and preparing antibody pair
CN109596839A (en) People and peptide element fast quantitative measurement method for detecting and kit
CN102876634B (en) PMSG (pregnant mare serum gonadotropin) double-antibody sandwich ELISA (enzyme-linked immunosorbent assay) kit
CN107436351B (en) Detection kit for reconstituted milk adulteration in fresh milk and detection method thereof
CN104749371A (en) An enzyme-linked immunosorbent assay kit for human nephroblastoma-overexpressed gene encoded protein
CN104730249A (en) Enzyme linked immunosorbent assay kit for detecting human epididymis secretory protein 4
CN107478848B (en) The kit and preparation method thereof of quantitative detection people NT-proBNP
CN102998457A (en) Competitive inhibition enzyme-linked immunosorbent assay (ELISA) method for grass carp tumor necrosis factors alpha
WO2018227643A1 (en) Target marker gp73 for detecting steatohepatitis and detection application method
CN102539778A (en) Enzyme linked immunosorbent assay kit for detecting recombinant human tumor necrosis factor-alpha
CN113025580B (en) Hybridoma cell strain, anti-fipronil monoclonal antibody produced by hybridoma cell strain and application of anti-fipronil monoclonal antibody
CN104833797A (en) ELISA method of detecting bispecific antibody MSBODY and application of the method
CN104764884A (en) Preparation method and application of anti-alpha-enolase antibody chromatography test strip
CN104730250A (en) Enzyme linked immunosorbent assay kit for detecting human kidney injury molecule-1
CN104777311B (en) The monoclonal antibody of anti human nerve somatomedin hNGF and the immue quantitative detection reagent box of hNGF
CN101261275A (en) Detection reagent kit for early ovarian cancer diagnosis
CN115873112B (en) Procalcitonin antibody and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Hu Yueqiu

Document name: Notification of Passing Examination on Formalities